Those 11 deals have a combined value of $64.4 billion, with the pharmaceuticals sector’s $30.45 billion in deals making up the largest portion of the total.
Here are the five top billion-dollar-plus healthcare deals that have been recorded in 2015.
1. AbbVie’s purchase of Pharmacyclics — $21 billion
2. Pfizer’s purchase of Hospira — $17 billion
3. Valeant Pharmaceuticals’ purchase of Salix Pharmaceuticals — $10.1 billion
4. Shire’s purchase of NPS Pharmaceuticals — $5.2 billion
5. Mallinckrodt’s purchase of Ikaria — $2.3 billion
More articles on healthcare finance:
House leaders in talks over $200B Medicare deal
12 recent hospital outlook and rating actions
10 healthcare CFOs in the headlines this week
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.